HE
TECH icon

Henry Ellenbogen’s Bio-Techne TECH Stock Holding History

Henry Ellenbogen’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5M Sell
501,963
-3,954,054
-89% -$214M 0.34% 35
2026
Q1 		$233M Buy
4,456,017
+2,367,126
+113% +$142M 2.4% 20
2025
Q4 		$123M Buy
2,088,891
+692,925
+50% +$42.1M 1.16% 27
2025
Q3 		$77.7M Buy
+1,395,966
New +$74.8M 0.58% 40

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Henry Ellenbogen's TECH Position: Q2 2026 in Review

Henry Ellenbogen reduced its Bio-Techne (TECH) stake by 89% in Q2 2026, selling an estimated $214M and leaving 501,963 shares worth $35.5M. The position accounts for 0.34% of the portfolio, ranked #35.

Henry Ellenbogen first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. The position peaked at $233M in Q1 2026. 591 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Henry Ellenbogen held 501,963 shares of Bio-Techne worth $35.5M as of Q2 2026.
  • Henry Ellenbogen sold 3,954,054 Bio-Techne shares in Q2 2026, an estimated $214M.
  • Bio-Techne made up 0.34% of Henry Ellenbogen's portfolio in Q2 2026, its #35 holding.
  • Henry Ellenbogen first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
  • Henry Ellenbogen's Bio-Techne position peaked at $233M in Q1 2026.
  • 591 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Durable Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.